Despite the rise of PSMA-ligand PET imaging, our real-world experience suggests that [18F]F-choline PET/CT should still be considered a valid and reliable diagnostic tool for primary staging of high-risk PCa patients or, in the case of inconclusive CI, providing an outcome improvement. Here, FOLH1 is linked to posterior cortical atrophy.